Meta-analysis of the need for nasogastric or nasojejunal decompression after gastrectomy for gastric cancer

Yang, Zhili; Zheng, Qi; Wang, Z

doi:10.1002/bjs.6198

Cited by 84 publications

(50 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many clinical studies have suggested that this practice does not provide any benefit but could increase patient discomfort and respiratory complications [1][2][3]. Furthermore, three recent meta-analyses concluded that nasogastric or nasojejunal decompression does not promote the recovery of gastrointestinal function or reduce the incidence of postoperative complications after gastrectomy for gastric cancer and after abdominal surgery [4][5][6].…”

Section: Introductionmentioning

confidence: 99%

Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial

et al. 2013

View full text Add to dashboard Cite

Background Only a few, small, monocentric randomized controlled trials (RCTs) have compared routine vs. no placement of a nasogastric or nasojejunal tube decompression (NG/NJT) in patients undergoing partial distal gastrectomy (PDG) for gastric cancer. However, to our knowledge, no multicenter prospective RCT has analyzed the role of decompression after both the Billroth II (BII) procedure and Roux-en-Y (RY) gastrojejunostomy.The aim of this study was to determine whether NG/NJT prevents the consequences of postoperative ileus after PDG for gastric cancer after both BII reconstruction and RY. Methods Two hundred seventy patients undergoing PDG for gastric cancer were randomly assigned NG/NJT placement (NG/NJT group) or not (no-NG/NJT group) with either Billroth II gastrojejunostomy or Roux-en-Y gastrojejunostomy. The patients were monitored for postoperative complications, mortality, and postoperative course. Results By January 2010 to June 2012, among 270 patients undergoing PDG for gastric cancer, 134 were randomly assigned to NG/NJT placement (NG/NJT group) and 136 to no decompression (no-NG/NJT group). Time to passage of flatus was significantly shorter in the NG/NJT group than in the no-NG/NJT group, but only after RY reconstruction (3.3 ± 1.5 vs. 4.3 ± 1.6 days, P \ 0.001, respectively).

show abstract

Section: Introductionmentioning

confidence: 99%

Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial

et al. 2013

View full text Add to dashboard Cite

show abstract

“…In addition, the group of patients that did not use NGI, had an earlier return of the intestinal function and lower index of pulmonary complications. However, in surgical procedures in the upper abdomen with higher gastric dilation risk or prolonged ileum (esophagectomies, gastroduodenopancreatectomies, ileal pouchs) still persists its indication for the shortest time possible, observing the cares described above 19,27,28 .…”

mentioning

confidence: 99%

Estenose esofágica por uso de sonda nasogástrica: reflexão sobre o uso indiscriminado

Ribeiro¹,

Lopes²,

Souza-Neto³

et al. 2011

ABCD, arq. bras. cir. dig.

View full text Add to dashboard Cite

show abstract

“…Some clinical studies and meta-analyses have suggested that nasogastric decompression does not provide any benefit but on the contrary it could increase patients’ discomfort and respiratory complications after gastrectomy [4,5,6,7]. However, the application of nasogastric decompression has been taken into consideration by most surgeons in order to decrease the incidence of postoperative anastomotic or duodenal stump leak, wound and pulmonary complications.…”

Section: Introductionmentioning

confidence: 99%

Nasogastric Decompression for Radical Gastrectomy for Gastric Cancer: A Prospective Randomized Controlled Study

Jia

Min

et al. 2011

Dig Surg

View full text Add to dashboard Cite

Background: The purpose of this study was to evaluate the necessity of a nasogastric decompression in radical gastrectomy for gastric cancer patients by a prospective randomized controlled trial. Methods: From 2007 to 2009, 161 gastric cancer patients who underwent radical gastrectomy were randomly selected and entered into three groups: tube group (TG), intra-operative tube group (ITG), and no-tube group (NTG). The variables studied among the groups were demographic characteristics, surgical characteristics, postoperative recovery and complications. Results: With respect to demographic and surgical characteristics, there were no significant differences among the 3 groups. The time of the first passage of flatus, tolerance of water intake, liquid diet and semiliquid diet were similar among TG, ITG and NTG. Postoperative hospital stay was increased in patients from TG compared to NTG (11.3 vs. 10.2 days, p = 0.031). The incidence of nausea was significantly higher in TG than in ITG or NTG (64 vs. 36.8 and 29.6%). The overall postoperative complication rate was not significantly different among these groups (20, 15.8 and 20.4% in TG, ITG and NTG, respectively, p = 0.612). Conclusions: Radical gastrectomy can be performed safely without nasogastric decompression for gastric cancer patients. The routine prophylactic nasogastric decompression is unnecessary.

show abstract

Meta-analysis of the need for nasogastric or nasojejunal decompression after gastrectomy for gastric cancer

Abstract: Routine nasogastric or nasojejunal decompression is unnecessary after gastrectomy for gastric cancer.

Cited by 84 publications

References 19 publications

Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial

Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial

Estenose esofágica por uso de sonda nasogástrica: reflexão sobre o uso indiscriminado

Nasogastric Decompression for Radical Gastrectomy for Gastric Cancer: A Prospective Randomized Controlled Study

Contact Info

Product

Resources

About